Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 11, 2011 - Issue 4
Submit an article Journal homepage
1,255
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Health technology assessments in personalized medicine: illustrations for cost–effectiveness analysis

Maarten J Postma University of Groningen, Unit of PharmacoEpidemiology and PharmacoEconomics (PE), The Netherlands. [email protected]
,
Cornelis Boersma University of Groningen, Unit of PharmacoEpidemiology and PharmacoEconomics (PE), The Netherlands
,
Dominique Vandijck Ghent University, Interuniversity Center for Health Economics Research, Belgium and Ghent University Hospital, Belgium and Hasselt University, Belgium
,
Stefan Vegter University of Groningen, Unit of PharmacoEpidemiology & PharmacoEconomics (PE), The Netherlands
,
Hoa H Le University of Groningen, Unit of PharmacoEpidemiology and PharmacoEconomics (PE), The Netherlands
&
Lieven Annemans Ghent University, Interuniversity Center for Health Economics Research, Belgium
Pages 367-369 | Published online: 09 Jan 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Koen Degeling, Hendrik Koffijberg & Maarten J. IJzerman. (2017) A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models. Expert Review of Pharmacoeconomics & Outcomes Research 17:1, pages 17-25.
Read now
Hans-Joerg Fugel, Mark Nuijten & Eric Faulkner. (2014) The application of economics concepts to stratified medicine—use of health economics data to support market access for stratified medicine interventions. Journal of Medical Economics 17:5, pages 305-311.
Read now

Articles from other publishers (12)

Stéphane Alcenat, François Maréchal & Florence Naegelen. (2020) Implementation of personalized medicine in a context of moral hazard and uncertainty about treatment efficacy. International Journal of Health Economics and Management 21:1, pages 81-97.
Crossref
Ingo Stiller, Arjen van Witteloostuijn & Bart Cambré. (2020) Do current radical innovation measures actually measure radical drug innovation?. Scientometrics 126:2, pages 1049-1078.
Crossref
Qi Cao, Erik Buskens, Hans L. Hillege, Tiny Jaarsma, Maarten Postma & Douwe Postmus. (2018) Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration. The European Journal of Health Economics 20:3, pages 475-482.
Crossref
Y. W. Francis Lam. 2019. Pharmacogenomics. Pharmacogenomics 385 394 .
Robert Terkola, Fernando Antoñanzas & Maarten Postma. (2017) Economic evaluation of personalized medicine: a call for real-world data. The European Journal of Health Economics 18:9, pages 1065-1067.
Crossref
Fernando Antoñanzas, Carmelo A. Juárez-Castelló & Roberto Rodríguez-Ibeas. (2016) Implementing personalized medicine with asymmetric information on prevalence rates. Health Economics Review 6:1.
Crossref
F. Antoñanzas, C. A. Juárez-Castelló & R. Rodríguez-Ibeas. (2014) Some economics on personalized and predictive medicine. The European Journal of Health Economics 16:9, pages 985-994.
Crossref
Ruth Schwarzer, Ursula Rochau, Kim Saverno, Beate Jahn, Bernhard Bornschein, Nikolai Muehlberger, Magdalena Flatscher-Thoeni, Petra Schnell-Inderst, Gaby Sroczynski, Martina Lackner, Imke Schall, Ansgar Hebborn, Karl Pugner, Andras Fehervary, Diana Brixner & Uwe Siebert. (2015) Systematic overview of cost–effectiveness thresholds in ten countries across four continents. Journal of Comparative Effectiveness Research 4:5, pages 485-504.
Crossref
Don Husereau, Deborah A. Marshall, Adrian R. Levy, Stuart Peacock & Jeffrey S. Hoch. (2014) HEALTH TECHNOLOGY ASSESSMENT AND PERSONALIZED MEDICINE: ARE ECONOMIC EVALUATION GUIDELINES SUFFICIENT TO SUPPORT DECISION MAKING?. International Journal of Technology Assessment in Health Care 30:2, pages 179-187.
Crossref
Altacílio Aparecido Nunes, Luane Marques de Mello, Lauro Wichert Ana, Paulo Mazzoncini de Azevedo Marques, Maria Eulália Lessa Dallora, Edson Zangiacomi Martinez, Antonio Pazin Filho & Eduardo Barbosa Coelho. (2013) Avaliação e incorporação de tecnologias em saúde: processo e metodologia adotados por um hospital universitário de alta complexidade assistencial. Cadernos de Saúde Pública 29:suppl 1, pages s179-s186.
Crossref
Maarten J. Postma, Cornelis Boersma, S. Vegter, Dominique Vandijck & L. Annemans. 2013. Pharmacogenomics. Pharmacogenomics 429 450 .
Grant T. Savage & Leo van der Reis. 2012. Health Information Technology in the International Context. Health Information Technology in the International Context 61 74 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.